Skip to content

NRSNW — Neurosense Therapeutics Ltd Institutional Holders · Q2 2026

Who owns Neurosense Therapeutics Ltd (NRSNW)? 3 institutions reported holding $10,372 in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Empery Asset Management, LP ($6,325), Clear Street Group Inc. ($3,974), UBS Group AG ($73).

RankInstitutionValueSharesChange
1Empery Asset Management, LP$6,325100,402Hold
2Clear Street Group Inc.$3,97463,085Trimmed
3UBS Group AG$731,163Hold

Source: SEC Form 13F filings · as of 2026-06-30